Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Eur J Pharmacol

From Bioblast
Journals in Bioblast
Journal title and website The European Journal of Pharmacology

Publications

 ReferencePublishedView
Aya 2022 Eur J PharmacolShiraki A, Oyama J, Shimizu T, Nakajima T, Yokota T, Node K (2022) Empagliflozin improves cardiac mitochondrial function and survival through energy regulation in a murine model of heart failure. Eur J Pharmacol 931: 175194.2022https://pubmed.ncbi.nlm.nih.gov/35987253/
Brodnanova 2021 Eur J PharmacolBrodnanova M, Hatokova Z, Evinova A, Cibulka M, Racay P (2021) Differential impact of imipramine on thapsigargin- and tunicamycin-induced endoplasmic reticulum stress and mitochondrial dysfunction in neuroblastoma SH-SY5Y cells. Eur J Pharmacol 902:174073.2021PMID: 33798597 Open Access
Abu Bakar 2020 Eur J PharmacolAbu Bakar MH, Shariff KA, Tan JS, Lee LK (2020) Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signaling pathways. Eur J Pharmacol 883:173371.2020PMID: 32712089
Bukowska 2019 Eur J PharmacolBukowska A, Schild L, Bornfleth P, Peter D, Wiese-Rischke C, Gardemann A, Isermann B, Walles T, Goette A (2019) Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells. Eur J Pharmacol 869:172875.2019PMID: 31877279 Open Access
Nambu 2019 Eur J PharmacolNambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S (2019) Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure. Eur J Pharmacol 866:172810.2019PMID: 31738936 Open Access
Lukasiak 2016 Eur J PharmacolŁukasiak A, Skup A, Chlopicki S, Łomnicka M, Kaczara P, Proniewski B, Szewczyk A, Wrzosek A (2016) SERCA, complex I of the respiratory chain and ATP-synthase inhibition are involved in pleiotropic effects of NS1619 on endothelial cells. Eur J Pharmacol 786:137-47.2016PMID: 27262382
Hansson 2015 Eur J PharmacolHansson MJ, Llwyd O, Morin D, de Paulis D, Arnoux T, Gouarné C, Koul S, Engblom H, Bordet T, Tissier R, Arheden H, Erlinge D, Halestrap AP, Berdeaux A, Pruss RM, Schaller S (2015) Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury. Eur J Pharmacol 760:7-19.2015PMID: 25895640
Nowak 2010 Eur J PharmacolNowak R, Wrzosek A, Lukasiak A, Rutkowska M, Adamus J, Gebicki J, Dolowy K, Szewczyk A, Tarasiuk J (2010) Effect of selected NAD+ analogues on mitochondria activity and proliferation of endothelial EA.hy926 cells. Eur J Pharmacol 640:102-11.2010PMID: 20447392
Wrzosek 2009 Eur J PharmacolWrzosek A, Lukasiak A, Gwozdz P, Malinska D, Kozlovski VI, Szewczyk A, Chlopicki S, Dolowy K (2009) Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function. Eur J Pharmacol 602:105-11.2009PMID: 19028489
Franciso 2007 Eur J PharmacolFranciso R, Perez-Tomas R, Gimenez-Bonafe P, Soto-Cerrato V, Gimenez-Xavier P, Santiago A (2007) Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines. Eur J Pharmacol 572:111-9.2007PMID: 17678643